Sialylation inhibition improves macrophage mediated tumor cell phagocytosis of breast cancer cells triggered by therapeutic antibodies of different isotypes

in Molecular and Cellular Oncology

• Marta Lustig
• Christoph Hahn
• Marie Leangen Herigstad
• Jan Terje Andersen
• Jeanette H. W. Leusen
• Renate Burger
• Thomas Valerius

Editorial: Unveiling the potential of CTCs in drug resistance mechanisms and personalized medicine

in Molecular and Cellular Oncology

• Chiara Nicolazzo
• Elisa Frullanti
• Paola Gazzaniga
• Maria Palmieri

When a negative (charge) is not a positive: sialylation and its role in cancer mechanics and progression

in Molecular and Cellular Oncology

• Issa Funsho Habeeb
• Toheeb Eniola Alao
• Daniella Delgado
• Alexander Buffone

Repurposing of PSMA-targeted diagnostic and therapeutic agents for the detection and treatment of giant cell tumors of bone

in Molecular and Cellular Oncology

• Brenna C. McAllister
• Nooshin Mesbahi
• Esther E. Dodson
• Sakinah Abdulsalam
• Clifford E. Berkman
• Leslie A. Caromile

Retraction: MiR-365a-3p-mediated regulation of HELLS/GLUT1 axis suppresses aerobic glycolysis and gastric cancer growth

in Molecular and Cellular Oncology

The skeleton: an overlooked regulator of systemic glucose metabolism in cancer?

in Molecular and Cellular Oncology

• Rucha Ronghe
• Adriana A. S. Tavares

The evolution of BRAF-targeted therapies in melanoma: overcoming hurdles and unleashing novel strategies

in Molecular and Cellular Oncology

• Saber Imani
• Ghazaal Roozitalab
• Mahdieh Emadi
• Atefeh Moradi
• Payam Behzadi
• Parham Jabbarzadeh Kaboli

Integrin α2 in the microenvironment and the tumor compartment of digestive (gastrointestinal) cancers: emerging regulators and therapeutic opportunities

in Molecular and Cellular Oncology

• Tiantian Liu
• Yanmei Gu
• Yuyu Zhang
• Yumin Li

Research progress of the SLFN family in malignant tumors

in Molecular and Cellular Oncology

• Jiale Yu
• Zhijuan Guo
• Junyi Zhang

The intricate interplay between ferroptosis and efferocytosis in cancer: unraveling novel insights and therapeutic opportunities

in Molecular and Cellular Oncology

• Ali Ahmadizad Firouzjaei
• Samira Mohammadi-Yeganeh

Development and validation of a tumor marker-based model for the prediction of lung cancer: an analysis of a multicenter retrospective study in Shanghai, China

in Molecular and Cellular Oncology

• Sheng Hu
• Qiang Guo
• Jiayue Ye
• Hongdan Ma
• Manyu Zhang
• Yunzhe Wang
• Bingen Wan
• Shengyu Qiu
• Xinliang Liu
• Guiping Luo

The capture of circulating tumor cells by Labyrinth system as a tool for early stage lung cancer detection

in Molecular and Cellular Oncology

• Peipei Jin
• Hong Li
• Mingran Xie
• Jie Tang
• Siming Zou
• Ruiting Wang
• Bin Yu
• Tao Chen
• Ju Zhang

A bibliometric and visualization analysis of entosis research from 2007 to 2024

in Molecular and Cellular Oncology

• Xinyu Yang
• Jiatao Tu
• Xinyi Zang
• Xuan Huang

Identification of lncRNA dual targeting PD-L1 and PD-L2 as a novel prognostic predictor for gastric cancer

in Molecular and Cellular Oncology

• Li-Na Zhang
• Jiong-Yu Chen
• Yu-Xin Liu
• Yue Zhang
• Liang-Li Hong
• Xin-Xin Li
• Shu-Hui Liu
• Shu-Qin Chen
• Lin Peng
• Yi-Teng Huang

CRISPR-based molecule-regulatory expression platform for specific immunotherapy of cancer

in Molecular and Cellular Oncology

• Lu Tong
• Linlin Wang
• Jun Dong

The relationship between keratin 18 and epithelial-derived tumors: as a diagnostic marker, prognostic marker, and its role in tumorigenesis

in Molecular and Cellular Oncology

• Jiazhi Yan
• Aiwei Yang
• Shuo Tu

METTL3 affects the biological function of lung adenocarcinoma through the FGF2/PI3K/AKT /mTOR pathway

in Molecular and Cellular Oncology

• Shaoting Chen
• Xiuqing Shen
• Pengju Cao
• Qianshun Chen
• Rongxin Zhong
• Yingping Cao

Serum extracellular vesicles 3’tRF-ThrCGTand 3’tRF-mtlleGAT combined with tumor markers can serve as minimally invasive diagnostic predictors for colorectal cancer

in Molecular and Cellular Oncology

• Jiefei Peng
• Fan Bu
• Lei Duan
• Anna Song

Comprehensive liquid biopsy analysis for monitoring NSCLC patients under second-line osimertinib treatment

in Molecular and Cellular Oncology

• Aliki Ntzifa
• Theodoros Marras
• Galatea Kallergi
• Athanasios Kotsakis
• Vasilis Georgoulias
• Evi Lianidou

Editorial: Revolutionizing cancer care: the promise of liquid biopsy assays for healthcare equity

in Molecular and Cellular Oncology

• Chad Brenner
• Carolyn Y. Fang

Characterization of ligand-receptor pair in acute myeloid leukemia: a scoring model for prognosis, therapeutic response, and T cell dysfunction

in Molecular and Cellular Oncology

• Chunlan Fu
• Di Qiu
• Mei Zhou
• Shaobo Ni
• Xin Jin

Expression of HOTAIR and PTGS2 as potential biomarkers in chronic myeloid leukemia patients in Brazil

in Molecular and Cellular Oncology

• Ana Paula Kubaski Benevides
• Anelis Maria Marin
• Denise K. Wosniaki
• Rafaela Noga Oliveira
• Gabriela Marino Koerich
• Bianca Nichele Kusma
• Eduardo Cilião Munhoz
• Dalila Luciola Zanette
• Mateus Nóbrega Aoki

Challenges and advances in glioblastoma targeted therapy: the promise of drug repurposing and biomarker exploration

in Molecular and Cellular Oncology

• William Han Bae
• Stefania Maraka
• Ahmad Daher

Inhibition of ATM or ATR in combination with hypo-fractionated radiotherapy leads to a different immunophenotype on transcript and protein level in HNSCC

in Molecular and Cellular Oncology

• Julia Meidenbauer
• Matthias Wachter
• Sebastian R. Schulz
• Nada Mostafa
• Lilli Zülch
• Benjamin Frey
• Rainer Fietkau
• Udo S. Gaipl
• Tina Jost